Dementia Research Centre
The Greater Manchester Dementia Research Centre (GMDRC) is Greater Manchester's leading clinical trial unit for the diseases causing dementia. We focus on putting the right patient into the right trial at the right time and have a 10-year track record of connecting people living with dementia with cutting edge studies run by either industry partners or the National Institute for Health Research (NIHR). We have close links to the University of Manchester through the faculty of Biology, Medicine and Health as well as the Geoffrey Jefferson Brain Research Centre Together with our GM partners, the Manchester Clinical Research Facility Health Innovation Manchester and others, we provide the infrastructure and expertise necessary to bring world-first clinical trials in the disease underlying dementia to Greater Manchester.
Together with patients and partners our aim is to be part of a global team that brings the first disease modifying medications to patients living with dementia. Working with the UK Brain Health Network (Bristol, Edinburgh, London, Cambridge, Oxford, Manchester, Cardiff and Belfast) we aim to bring molecular diagnostics into routine practice in the UK. Other research areas include neuroimaging, using novel modalities to study the earliest parts of the brain affected by Alzheimer disease, and using the state-of-the-art PET-MRI scanner located in St. Mary's Hospital and funded by the Dementias Platform UK